Status:
UNKNOWN
Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis
Lead Sponsor:
University Hospital, Angers
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate 3 imaging techniques and their associations : MRI, CTscanner and enhanced contrast ultrasound for the diagnosis of small (\< 3 cm) hepatocellular carcinoma for...
Detailed Description
With the improvement of cirrhosis complications coverage, hepatocellular carcinoma (HCC) tend to become the main cause of mortality for cirrhotic patients. Currently, the incidence of the HCC increase...
Eligibility Criteria
Inclusion
- age \> 18 hears
- presence of one or several nodules \< 3 cm
- known or suspected cirrhosis
Exclusion
- psychiatric disease
- contraindication to one of the 3 imaging examinations (CTscanner, MRI, enhanced contrast ultrasound
- patient already treated by chemoembolization
- recurrence on the coagulation zone of a nodule already treated by per-cutaneous tumour destruction
- presence of a tumour (\> 3 cm) associated to the nodule
- pregnant woman or breast-feeding woman
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00848952
Start Date
March 1 2009
Last Update
February 4 2010
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France
2
Hôpital Saint-André
Bordeaux, France, 33300
3
Chu
Caen, France, 14033
4
hôpital Beaujon
Clichy, France, 92110